TRY 10.0
(-2.34%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 13.88 Billion | 10.84 Billion | 3.28 Billion | 2.05 Billion |
Cost of Revenue | 11.41 Billion | 7.84 Billion | 2.13 Billion | 1.53 Billion |
Gross Profit | 2.46 Billion | 2.99 Billion | 1.15 Billion | 522.96 Million |
Operating Expenses | 790.93 Million | 75.76 Million | 62.12 Million | 71.65 Million |
Selling, General and Administrative Expenses | 609.97 Million | 31.43 Million | 32.36 Million | 57.9 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | 180.96 Million | -44.32 Million | -29.75 Million | -13.75 Million |
Cost and Expenses | 12.2 Billion | 7.92 Billion | 2.19 Billion | 1.6 Billion |
Operating Income | 1.67 Billion | 2.92 Billion | 1.09 Billion | 451.3 Million |
Interest Expense | - | 4.66 Billion | 889.62 Million | 618.57 Million |
Income Tax Expense | -402.98 Million | 532.38 Million | -596.93 Million | -149.72 Million |
Earnings before Tax | 980.82 Million | -417.87 Million | 1.1 Billion | 193.18 Million |
Net Income | 1.26 Billion | -784.88 Million | 1.7 Billion | 233.51 Million |
Earnings Per Share Basic | 0.57 | -0.32 | 0.61 | 0.10 |
Earnings Per Share Diluted | 0.57 | -0.32 | 0.61 | 0.10 |
Weighted Average Shares Outstanding | 2.23 Billion | 2.44 Billion | 2.44 Billion | 2.44 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.23 Billion | 2.44 Billion | 2.44 Billion | 2.44 Billion |
Gross Margin | 0.18 | 0.28 | 0.35 | 0.25 |
EBIT Margin | 0.52 | 0.47 | 0.73 | 0.55 |
Profit Margin | 0.09 | -0.07 | 0.52 | 0.11 |
EBITDA | 7.19 Billion | 4.25 Billion | 3.22 Billion | 1.43 Billion |
Earnings Before Tax Margin | 0.12 | 0.27 | 0.33 | 0.22 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 2.86 Billion | 2.91 Billion | 13.88 Billion | 5.89 Billion | 3.88 Billion | 5.45 Billion |
Cost of Revenue | 2.67 Billion | 2.48 Billion | 11.41 Billion | 5.5 Billion | 3.41 Billion | 4.33 Billion |
Gross Profit | 193.13 Million | 434.52 Million | 2.46 Billion | 385.32 Million | 464.71 Million | 1.12 Billion |
Operating Expenses | 150.19 Million | 231.36 Million | 101.95 Million | 421.92 Million | 570.84 Million | 58 Million |
Selling, General and Administrative Expenses | 125.45 Million | 65.51 Million | - | 108.98 Million | 70.37 Million | 12.56 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 24.73 Million | 3.38 Billion | - | - | 500.46 Million | 3.54 Billion |
Cost and Expenses | 2.82 Billion | 2.71 Billion | 11.51 Billion | 5.93 Billion | 3.98 Billion | 4.38 Billion |
Operating Income | 42.94 Million | 158.86 Million | 1.86 Billion | 102.69 Million | -106.12 Million | 1.05 Billion |
Interest Expense | 733.33 Million | 838.77 Million | - | - | - | 453.95 Million |
Income Tax Expense | 58.53 Million | -169.72 Million | 402.98 Million | 990.9 Million | 854.31 Million | 210.43 Million |
Earnings before Tax | -2.5 Billion | -1.84 Billion | 980.82 Million | 1.58 Billion | -1.05 Billion | 2.35 Billion |
Net Income | -2.03 Billion | -1.48 Billion | 1.26 Billion | 466.83 Million | -84.99 Million | 1.85 Billion |
Earnings Per Share Basic | -0.83 | -0.61 | - | 0.21 | -0.04 | 0.76 |
Earnings Per Share Diluted | -0.83 | -0.61 | - | 0.21 | -0.04 | 0.76 |
Weighted Average Shares Outstanding | 2.44 Billion | 2.44 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.44 Billion |
Weighted Average Shares Outstanding (Diluted) | 2.44 Billion | 2.44 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.44 Billion |
Gross Margin | 0.07 | 0.15 | 0.18 | 0.07 | 0.12 | 0.21 |
EBIT Margin | 0.61 | 0.01 | - | 0.57 | 0.39 | 0.69 |
Profit Margin | -0.71 | -0.51 | 0.09 | 0.08 | -0.02 | 0.34 |
EBITDA | 1.75 Billion | 41.78 Million | - | 3.35 Billion | 1.51 Billion | 3.78 Billion |
Earnings Before Tax Margin | 0.01 | 0.05 | 0.13 | 0.02 | -0.03 | 0.19 |
VANTABIO
ALMOU
DEEPAKCHEM
CUBEXTUB
ZWELCAST
ICDSLTD